Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance-Reference-Cited by-同舟云学术

Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance

Published:2023-06-19 Issue:19 Volume:129 Page:2927-2940
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Daniels Anthony B.¹²,Tirosh Amit³^ORCID,Huntoon Kristin⁴,Mehta Gautam U.⁵,Spiess Philippe E.⁶,Friedman Debra L.²⁷,Waguespack Steven G.⁸,Kilkelly Jill E.⁹,Rednam Surya¹⁰,Pruthi Sumit¹¹,Jonasch Eric A.¹²,Baum Laura¹³^ORCID,Chahoud Jad⁶^ORCID,

Affiliation:

1. Division of Ocular Oncology and Pathology Department of Ophthalmology & Visual Sciences Vanderbilt University Medical Center Nashville Tennessee USA

2. Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA

3. Neuroendocrine Tumors Service Sheba Medical Center and Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

4. Department of Neurosurgery The University of Texas MD Anderson Cancer Center Houston Tennessee USA

5. The House Clinic Los Angeles California USA

6. Department of Genitourinary Oncology Moffitt Cancer Center Tampa Florida USA

7. Division of Hematology/Oncology Department of Pediatrics Vanderbilt University Medical Center Nashville Texas USA

8. Department of Endocrine Neoplasia and Hormonal Disorders The University of Texas MD Anderson Cancer Center Houston Texas USA

9. Division of Pediatric Anesthesia Department of Anesthesiology Vanderbilt University Medical Center Nashville Tennessee USA

10. Division of Pediatric Hematology‐Oncology Department of Pediatrics Baylor College of Medicine Houston Texas USA

11. Division of Pediatric Neuroradiology Department of Radiology Vanderbilt University Medical Center Nashville Tennessee USA

12. Department of Genitourinary Medical Oncology Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas USA

13. Division of Hematology/Oncology Department of Internal Medicine Vanderbilt University Medical Center Nashville Tennessee USA

Abstract

Von Hippel‐Lindau disease is a rare inherited cancer‐predisposition syndrome. The authors report the updated recommendations for the multiorgan surveillance protocols.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference89 articles.

1. Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome

2. von Hippel-Lindau disease

3. von Hippel–Lindau disease: A clinical and scientific review

4. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer

5. VHL, the story of a tumour suppressor gene

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Adult Central Nervous System Hemangioblastomas: A Systematic Review;World Neurosurgery;2024-11

2. Multiple Primary Paragangliomas in a Pediatric Patient With von Hippel Lindau: A Diagnostic Dilemma;JCEM Case Reports;2024-08-14

3. Belzutifan: a novel therapeutic for the management of von Hippel–Lindau disease and beyond;Future Oncology;2024-04-19

4. Diversities of Mechanism in Patients with VHL Syndrome and diabetes: A Report of Two Cases and Literature Review;Diabetes, Metabolic Syndrome and Obesity;2024-04

5. Predictors of Progression in a Series of 81 Adult Patients Surgically Managed for an Intracranial Hemangioblastoma: Implications for the Postoperative Follow-Up;Cancers;2024-03-23